Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Journal
-
- The Lancet
-
The Lancet 394 (10216), 2271-2281, 2019-12
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360579818142284928
-
- ISSN
- 01406736
-
- Data Source
-
- Crossref